Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
Indiva Shares Tumble 10% as Cannabis LP Faces Market Headwinds
NDVAF dropped to $0.02 on elevated volume as the Canadian licensed producer confronts ongoing sector challenges.
RCMP Bust Exposes $5.5M Black Market Cannabis Network Threat
Federal police dismantle major illegal online cannabis operation, highlighting persistent black market competition facing licensed operators
Healthcare Giants Eye Cannabis Tech as Medical Market Matures
Major healthcare corporations explore cannabis sector opportunities as regulatory clarity improves and medical applications expand nationwide.
Cannabis Stocks Show Mixed Signals as Market Seeks Direction
Cannabis equities display uneven performance patterns as investors weigh regulatory uncertainty against operational improvements across the sector.
House Bill Targets Federal Cannabis Research Barriers at Universities
New bipartisan legislation aims to remove federal funding restrictions that limit university cannabis research programs nationwide.
Planet 13 Holdings Surges 5.2% as Cannabis MSO Shows Momentum
Planet 13 Holdings climbed 5.21% to $0.91 on elevated volume as the multi-state cannabis operator continues recovery efforts.
Green Thumb Industries Surges 7% as MSO Momentum Builds
GTBIF climbed to $6.56 on elevated volume of 1.2M shares, marking a significant single-day gain for the multi-state operator.
SNDL Reports Q2 2025 Results: Revenue Growth Amid Market Pressures
SNDL Inc delivers mixed Q2 2025 performance with revenue expansion offset by margin compression in competitive Canadian cannabis landscape.
GOP Senators Target Cannabis Hospitalization Costs in New Federal Bill
Republican lawmakers propose mandatory tracking of marijuana-related medical expenses, adding regulatory scrutiny to industry growth narrative.
SNDL Reports Q2 2025 Results: Revenue Growth Amid Market Headwinds
SNDL Inc delivers mixed Q2 performance with revenue gains offset by margin pressures in challenging Canadian cannabis market conditions.
Prohibition's Scientific Cost: Cannabis Research Deficit Hampers Industry Growth
Decades of cannabis prohibition created a research gap that continues to limit medical applications and market expansion potential across the sector.
Senators Push Cannabis-Medicaid Study Bill Backed by Prohibition Group
Bipartisan Senate legislation seeks federal analysis of cannabis programs' impact on Medicaid costs, raising investor concerns about regulatory scrutiny.
Quantum Computing Breakthrough Could Disrupt Cannabis Analytics
IonQ's major contract win signals quantum computing's entry into complex data analysis sectors, potentially revolutionizing cannabis market intelligence.
Minnesota Youth Cannabis Use Drops Post-Legalization, Easing Investor Fears
New survey data shows declining youth consumption rates in Minnesota following adult-use legalization, potentially reducing regulatory headwinds for cannabis operators.
TerrAscend Corp Volume Surges 6.5x as Cannabis MSO Draws Attention
TerrAscend Corp (TSNDF) experienced extraordinary trading volume of 2.03M shares, representing a 6.5x spike above its 30-day average amid renewed investor interest.
Ayurcann Holdings Trades Near Zero as Cannabis Stock Struggles
AYURF shares hover at $0.00, reflecting severe market challenges for the Canadian cannabis processor amid industry-wide pressures.
Centr Brands Hovers at 52-Week Low Amid Broader CBD Sector Struggles
CNTRF trades at $0.01 with minimal volume as CBD company faces significant valuation pressure in challenging market conditions.
Cannabis Media Giant Partners With Justice Group On Prison Reform Push
High Times teams with Last Prisoner Project to spotlight incarcerated cannabis offenders, reflecting industry's growing focus on social equity initiatives.
Cannabis Accessories Market Thrives Despite Digital Ad Restrictions
E-commerce platforms find creative workarounds as advertising limitations fuel organic growth strategies in the booming cannabis accessories sector.
Jazz Pharmaceuticals Surges Near 52-Week High at $199.31
JAZZ trades within 2% of its annual peak despite daily decline, signaling strong momentum in specialty pharma sector amid robust revenue performance.